CFH and stage 5 chronic kidney disease: Patients with MCP-mutations often show a spontaneous remission, as initially in our patient, and have a lower risk to progress to end-stage renal disease than patients with other mutations in the genes for regulators for the alternative pathway complement system (e.g., factor H, factor I) [2].